Standard name |
KERLEY_RESPONSE_TO_CISPLATIN_DN |
Systematic name |
M17702 |
Brief description |
Genes genes down-regulated in NT2/D1 cells (embryonal carcinoma) in response to treatment with cisplatin [PubChem=2767]. |
Full description or abstract |
Testicular germ cell cancers remain one of the few solid tumors routinely cured in advanced stages with conventional cisplatin-based chemotherapy. The mechanisms remain largely unknown. Through use of gene-expression array profiling we define immediate transcriptional targets in response to cisplatin in testicular germ cell-derived human embryonal carcinoma cells. We report 46 genes upregulated and five genes repressed by cisplatin. Several of these gene products, including FAS, TRAILR3, PHLDA3, LRDD, and IER3 are previously implicated in the apoptotic death receptor pathway, while others including SESN1, FDXR, PLK3, and DDIT4 are known mediators of reactive oxygen species generation. Approximately 54% of the upregulated genes are established or suspected downstream targets of p53. Specific siRNA to p53 prevents cisplatin-mediated activation of p53 and p53 pathway genes and renders embryonal carcinoma cells relatively resistant to cisplatin cytotoxicity. Interestingly, in p53 knockdown cells nearly the entire set of identified cisplatin targets fail to respond or have a diminished response to cisplatin, suggesting that many are new direct or indirect targets of p53 including GPR87, STK17A, INPP5D, FLJ11259, and EPS8L2. The data indicate that robust transcriptional activation of p53 is linked to the known hypersensitivity of testicular germ cell tumors to chemotherapy. Many of the gene products may participate in the unique curability of this disease. |
Collection |
C2: Curated CGP: Chemical and Genetic Perturbations |
Source publication |
Pubmed 15940259 Authors: Kerley-Hamilton JS,Pike AM,Li N,DiRenzo J,Spinella MJ |
Exact source |
Table 1: fold change < 0 |
Related gene sets |
(show 1 additional gene sets from the source publication)
|
External links |
|
Filtered by similarity ?
|
|
Source species |
Homo sapiens |
Contributed by |
Leona Saunders (MSigDB Team) |
Source platform or identifier namespace |
HUMAN_GENE_SYMBOL |
Dataset references |
|
Download gene set |
format: grp | gmt | xml | json | TSV metadata |
Compute overlaps ? |
(show collections to investigate for overlap with this gene set)
|
Compendia expression profiles ? |
NG-CHM interactive heatmaps
(Please note that clustering takes a few seconds)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Legacy heatmaps (PNG)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
|
Advanced query |
Further investigate
these 5 genes
|
Gene families ? |
Categorize these
5 genes by gene family
|
Show members |
(show 5 source identifiers mapped to 5 genes)
Source Id |
NCBI (Entrez) Gene Id |
Gene Symbol |
Gene Description |
CYP26A1 |
1592 |
CYP26A1 |
cytochrome P450 family 26 subfamily A membe... |
HESX1 |
8820 |
HESX1 |
HESX homeobox 1 [Source:HGNC Symbol;Acc:HGN... |
HMGCS1 |
3157 |
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 [... |
LPIN1 |
23175 |
LPIN1 |
lipin 1 [Source:HGNC Symbol;Acc:HGNC:13345] |
MYC |
4609 |
MYC |
MYC proto-oncogene, bHLH transcription fact... |
|
Version history |
|